GB0921378D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB0921378D0
GB0921378D0 GBGB0921378.6A GB0921378A GB0921378D0 GB 0921378 D0 GB0921378 D0 GB 0921378D0 GB 0921378 A GB0921378 A GB 0921378A GB 0921378 D0 GB0921378 D0 GB 0921378D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0921378.6A
Other versions
GB2466110B (en
GB2466110A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntopix Group PLC
Original Assignee
Syntopix Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntopix Group PLC filed Critical Syntopix Group PLC
Publication of GB0921378D0 publication Critical patent/GB0921378D0/en
Publication of GB2466110A publication Critical patent/GB2466110A/en
Application granted granted Critical
Publication of GB2466110B publication Critical patent/GB2466110B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
GB0921378A 2008-12-09 2009-12-07 Antibacterial formulation for use in the treatment of acne Expired - Fee Related GB2466110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0822394.3A GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations

Publications (3)

Publication Number Publication Date
GB0921378D0 true GB0921378D0 (en) 2010-01-20
GB2466110A GB2466110A (en) 2010-06-16
GB2466110B GB2466110B (en) 2011-01-05

Family

ID=40289694

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0822394.3A Ceased GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations
GB0921378A Expired - Fee Related GB2466110B (en) 2008-12-09 2009-12-07 Antibacterial formulation for use in the treatment of acne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0822394.3A Ceased GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations

Country Status (1)

Country Link
GB (2) GB0822394D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015184347A1 (en) * 2014-05-29 2015-12-03 Metabeauty, Inc. Methods and compositions for the use of silver to prevent and treat acne

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147182A (en) * 1961-03-20 1964-09-01 Johnson & Johnson Antiseptic mixture of decamethylene 1, 10-bis-4-aminoquinaldinium salt and cetyl pridinium salt
RO59301A2 (en) * 1972-07-26 1976-01-15
JP2000212090A (en) * 1999-01-18 2000-08-02 Mitsuko Ito Skin-modifying agent
US20080070875A1 (en) * 2006-09-11 2008-03-20 Majewski George P Acne treatment compositions and methods of use
GB0618695D0 (en) * 2006-09-22 2006-11-01 Syntopix Ltd Formulations
GB0710899D0 (en) * 2007-06-07 2007-07-18 Syntopix Ltd Formulations
JP2008110999A (en) * 2008-02-04 2008-05-15 Mandom Corp Antibacterial composition and deodorant agent
GB2456376A (en) * 2008-12-22 2009-07-15 Syntopix Ltd Antibacterial/anti-acne formulations comprising a halogenated salicylanilide in combination with one or more anti-acne agents

Also Published As

Publication number Publication date
GB2466110B (en) 2011-01-05
GB2466110A (en) 2010-06-16
GB0822394D0 (en) 2009-01-14

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
ZA201106050B (en) Dye-polymers formulations
GB0711656D0 (en) Formulations
GB0716385D0 (en) Formulations
GB0823269D0 (en) Formulations
GB0712884D0 (en) Formulations
GB0821789D0 (en) Formulations
GB0809979D0 (en) Formulations
GB0919210D0 (en) Formulations
GB0711957D0 (en) Formulations
IL219162A0 (en) Improved formulations
EP2307021A4 (en) Formulations
GB0822633D0 (en) Formulation
GB0806978D0 (en) Novel formulations
ZA201004772B (en) Novel formulation
GB0810232D0 (en) Formulations
GB0814376D0 (en) Formulation
GB0705179D0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
IL217390A0 (en) Formulations
GB0811447D0 (en) Formulations
GB0816876D0 (en) Formulations

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20131207